Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3849897, 12 pages
http://dx.doi.org/10.1155/2016/3849897
Research Article

Partially Purified Extracts of Sea Anemone Anemonia viridis Affect the Growth and Viability of Selected Tumour Cell Lines

1Istituto di Biomedicina e di Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Via Ugo La Malfa 153, 90146 Palermo, Italy
2Laboratory of Molecular Ecology and Biotechnology, National Research Council, Institute for Marine and Coastal Environment (IAMC-CNR), Detached Unit of Capo Granitola, Torretta Granitola, 91021 Trapani, Italy

Received 23 March 2016; Revised 26 July 2016; Accepted 22 August 2016

Academic Editor: Michael Kalafatis

Copyright © 2016 Matteo Bulati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. De Vries and P. M. Beart, “Fishing for drugs from the sea: status and strategies,” Trends in Pharmacological Sciences, vol. 16, no. 8, pp. 275–279, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Aneiros and A. Garateix, “Bioactive peptides from marine sources: pharmacological properties and isolation procedures,” Journal of Chromatography B, vol. 803, no. 1, pp. 41–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Blunt, B. R. Copp, R. A. Keyzers, M. H. Munro, and M. R. Prinsep, “Marine natural products,” Natural Product Reports, vol. 32, no. 2, pp. 116–211, 2015. View at Google Scholar
  4. H. K. Kang, C. H. Seo, and Y. Park, “Marine peptides and their anti-infective activities,” Marine Drugs, vol. 13, no. 1, pp. 618–654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Hartmann and H. Meisel, “Food-derived peptides with biological activity: from research to food applications,” Current Opinion in Biotechnology, vol. 18, no. 2, pp. 163–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-S. Kong, J.-A. Kim, S.-S. Bak, H.-G. Byun, and S.-K. Kim, “Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes,” The Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 276–281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Najafian and A. S. Babji, “A review of fish-derived antioxidant and antimicrobial peptides: their production, assessment, and applications,” Peptides, vol. 33, no. 1, pp. 178–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Rajanbabu and J.-Y. Chen, “Antiviral function of tilapia hepcidin 1-5 and its modulation of immune-related gene expressions against infectious pancreatic necrosis virus (IPNV) in Chinook salmon embryo (CHSE)-214 cells,” Fish and Shellfish Immunology, vol. 30, no. 1, pp. 39–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D.-H. Ngo, T.-S. Vo, D.-N. Ngo, I. Wijesekara, and S.-K. Kim, “Biological activities and potential health benefits of bioactive peptides derived from marine organisms,” International Journal of Biological Macromolecules, vol. 51, no. 4, pp. 378–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Aminin, E. S. Menchinskaya, E. A. Pisliagin, A. S. Silchenko, S. A. Avilov, and V. I. Kalinin, “Anticancer activity of sea cucumber triterpene glycosides,” Marine Drugs, vol. 13, no. 3, pp. 1202–1223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Cherigo, D. Lopez, and S. Martinez-Luis, “Marine natural products as breast cancer resistance protein inhibitors,” Marine Drugs, vol. 13, no. 4, pp. 2010–2029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Imperatore, F. D'Aniello, A. Aiello et al., “Phallusiasterols A and B: two new sulfated sterols from the mediterranean tunicate Phallusia fumigata and their effects as modulators of the PXR receptor,” Marine Drugs, vol. 12, no. 4, pp. 2066–2078, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Khazir, D. L. Riley, L. A. Pilcher, P. De-Maayer, and B. A. Mir, “Anticancer agents from diverse natural sources,” Natural Product Communications, vol. 9, no. 11, pp. 1655–1669, 2014. View at Google Scholar · View at Scopus
  14. W. R. Sawadogo, R. Boly, C. Cerella, M. H. Teiten, M. Dicato, and M. Diederich, “A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2012,” Molecules, vol. 20, no. 4, pp. 7097–7142, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Nobili, D. Lippi, E. Witort et al., “Natural compounds for cancer treatment and prevention,” Pharmacological Research, vol. 59, no. 6, pp. 365–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Turk and W. R. Kem, “The phylum Cnidaria and investigations of its toxins and venoms until 1990,” Toxicon, vol. 54, no. 8, pp. 1031–1037, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Rocha, L. Peixe, N. C. M. Gomes, and R. Calado, “Cnidarians as a source of new marine bioactive compounds—an overview of the last decade and future steps for bioprospecting,” Marine Drugs, vol. 9, no. 10, pp. 1860–1886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Frazão, V. Vasconcelos, and A. Antunes, “Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview,” Marine Drugs, vol. 10, no. 8, pp. 1812–1851, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Beeton, M. W. Pennington, and R. S. Norton, “Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases,” Inflammation & Allergy—Drug Targets, vol. 10, no. 5, pp. 313–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Belardinelli, G. Liu, C. Smith-Maxwell et al., “A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias,” The Journal of Pharmacology and Experimental Therapeutics, vol. 344, no. 1, pp. 23–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Subramanian, T. Sangappellai, R. C. Rajak, and B. Diraviam, “Pharmacological and biomedical properties of sea anemones Paracondactylis indicus, Paracondactylis sinensis, Heteractis magnifica and Stichodactyla haddoni from East coast of India,” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 9, pp. 722–726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. I. Monroy-Estrada, L. Segura-Puertas, S. Galván-Arzate, A. Santamaría, and J. Sánchez-Rodríguez, “The crude venom from the sea anemone Stichodactyla helianthus induces haemolysis and slight peroxidative damage in rat and human erythrocytes,” Toxicology in Vitro, vol. 21, no. 3, pp. 398–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Stabili, R. Schirosi, M. G. Parisi, S. Piraino, and M. Cammarata, “The mucus of Actinia equina (Anthozoa, Cnidaria): an unexplored resource for potential applicative purposes,” Marine Drugs, vol. 13, no. 8, pp. 5276–5296, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Ayed, M. Boussabbeh, W. Zakhama, C. Bouaziz, S. Abid, and H. Bacha, “Induction of cytotoxicity of Pelagia noctiluca venom causes reactive oxygen species generation, lipid peroxydation induction and DNA damage in human colon cancer cells,” Lipids in Health and Disease, vol. 10, article 232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Ayed, A. Dellai, H. B. Mansour, H. Bacha, and S. Abid, “Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775),” Annals of Clinical Microbiology and Antimicrobials, vol. 11, article 15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Rastogi, S. Biswas, A. Sarkar, and D. Chakrabarty, “Anticoagulant activity of Moon jellyfish (Aurelia aurita) tentacle extract,” Toxicon, vol. 60, no. 5, pp. 719–723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Schupp, C. Kohlert-Schupp, S. Whitefield et al., “Cancer chemopreventive and anticancer evaluation of extracts and fractions from marine macro- and microorganisms collected from Twilight Zone waters around Guam,” Natural Product Communications, vol. 4, no. 12, pp. 1717–1728, 2009. View at Google Scholar · View at Scopus
  28. M. Trapani, M. Parisi, M. Toubiana et al., “First evidence of antimicrobial activity of neurotoxin 2 from Anemonia viridis (Cnidaria),” Invertebrate Survival Journal, vol. 11, pp. 182–191, 2014. View at Google Scholar
  29. A. Nicosia, T. Maggio, S. Mazzola, and A. Cuttitta, “Evidence of accelerated evolution and ectodermal-specific expression of presumptive BDS toxin cDNAs from Anemonia viridis,” Marine Drugs, vol. 11, no. 11, pp. 4213–4231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Nicosia, T. Maggio, S. Mazzola, F. Gianguzza, A. Cuttitta, and S. Costa, “Characterization of small hsps from Anemonia viridis reveals insights into molecular evolution of alpha crystallin genes among cnidarians,” PLoS ONE, vol. 9, no. 9, Article ID e105908, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Deghrigue, A. Dellai, N. Akremi, V. Le Morvan, J. Robert, and A. Bouraoui, “Evaluation of antiproliferative and antioxidant activities of the organic extract and its polar fractions from the Mediterranean gorgonian Eunicella singularis,” Environmental Toxicology and Pharmacology, vol. 36, no. 2, pp. 339–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. H. I. Monroy-Estrada, Y. I. Chirino, I. E. Soria-Mercado, and J. Sánchez-Rodríguez, “Toxins from the Caribbean sea anemone Bunodeopsis globulifera increase cisplatin-induced cytotoxicity of lung adenocarcinoma cells,” Journal of Venomous Animals and Toxins including Tropical Diseases, vol. 19, no. 1, article 12, 2013. View at Publisher · View at Google Scholar
  33. J. P. Van Brussel, G. J. Van Steenbrugge, J. C. Romijn, F. H. Schröder, and G. H. J. Mickisch, “Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins,” European Journal of Cancer, vol. 35, no. 4, pp. 664–671, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. G. L. Mariottini and L. Pane, “Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications,” Toxins, vol. 6, no. 1, pp. 108–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus